Vascular malformations (I). Concept, classification, pathogenesis and clinical features;Malformaciones vasculares (I). Concepto, clasificación, fisiopatogenia y manifestaciones clínicas

Actas Dermo-Sifiliograficas

Volumn 98, Issue 3, 2007, Pages 141-158

  Redondo, Pedro ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Arterio venous; Klippel Trenaunay; Lymphatic; Vascular malformation; Venous

Indexed keywords

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIOVENOUS MALFORMATION; BLOOD FLOW; BLUE NEVUS; BRAIN VEIN MALFORMATION; CLINICAL FEATURE; COBB SYNDROME; CONGENITAL BLOOD VESSEL MALFORMATION; CUTIS MARMORATA TELANGIECTATICA CONGENITA; DISEASE CLASSIFICATION; ESTHETICS; FACOMATOSIS PIGMENTOVASCULARES; FOLLOW UP; GLOMUS TUMOR; HEMANGIOMA; HUMAN; MEDICAL SOCIETY; MORBIDITY; MULTIPLE CANCER; OSTEOCHONDROMA; PATHOGENESIS; PATIENT CARE; PRACTICE GUIDELINE; REMISSION; REVIEW; STURGE WEBER SYNDROME; VEIN MALFORMATION;

EID: 34250682982     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70038-8     Document Type: Review

References (105)

1. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003;48:477-93.
2. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy. Clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138:1567-76.
3. Enjolras O, Mulliken JB, Boon L, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous anomaly. Plast Reconstr Surg. 2001;107: 1647-54.
4. Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imagin Clin N Am. 2002;10:363-88.
5. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69: 412.
6. Hand JL, Frieden IJ. Vascular birthmarks of infancy: resolving nosologic confusin. Am J Med Genet. 2002;108: 257-64.
7. Ly JQ, Sanders TG, San Diego JW. Hemangioma of the triceps muscle. AJR Am J Roentgenol. 2003;181:544.
8. Kuo P-H, Chang Y-C, Liou J-H, Lee J-M. Mediastinal cavernous haemangioma in a patient with Klippel-Trenaunay syndrome. Thorax. 2003;58:183-4.
9. Mulliken JB. Vascular malformations of the head and neck. En: Mulliken JB, Young AE, editors. Vascular birthmarks: Hemangiomas and vascular malformations. Philadelphia: WB Saunders; 1988.
10. Belov S. Classification of congenital vascular defects. Int Angiol. 1990;9:141-6.
11. St. Belov DA, Loose J, Weber, editors.Vascular malformations. Einhorn Presse Verlag. Periodica Angiologica; 1989. p. 25-7.
12. Waner M, Suen JY. A classification of congenital vascular lesions. En: Waner M, Suen JY, editors. Hemangiomas and vascular malformations of the head and neck. Chapter 1. New York: Wiley-Liss; 1999. p. 1-12.
13. Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33:99-103.
14. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894.
15. Sako Y, Varco R. Arteriovenous fistula: results of management of congenital and acquired forms, blood flow measurements, and observations on proximal arterial degeneration. Surgery. 1970;67:40.
16. Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000; 31:462-71.
17. Vikkula M, Boon L, Carraway KL 3rd, Calvert JT, Diamond AJ, Goumnerov B, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinasa TIE2. Cell. 1996;87:1181.
18. Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3:1583-7.
19. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessels formation. Nature. 1995;376:70-4.
20. Boon LM, Brouillard P, Irrthum A, Karttunen L, Warman ML, Rudolph R, et al. A gene for inherited cutaneous venous anomalies («glomangiomas») localizes to chromosome 1p21-22. Am J Hum Genet. 1999;65:125-33.
21. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet. 1999;8:2325-33.
22. Tian XL, Kadaba R, You SA, Liu M, Timur AA, Yang L, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature. 2004;427:640-5.
23. Eng C. PTEN: one gene, many syndromes. Hum Mutat. 2003;22:183-98.
24. Smoller BR, Rosen S. Port-wine stains: a disease of altered neural modulation of blood vessels. Arch Dermatol. 1986;122:177.
25. Rydy M, Malm M, Jernbeck J, Dalsgaard C. Ectatic blood vessels in port-wine stains lack innervation: possible role in pathogenesis. Plast Reconstr Surg. 1991;87:419.
26. Ornstein E, Blesser WB, Young WL, Pile-Spellman J. A computer simulation of the haemodynamic effects of intracranial arteriovenous malformation occlusion. Neurol Res. 1994;16:345-52.
27. Sánchez-Carpintero I, Mihm MC, Mizeracki A, Waner M, North PE. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol. 2004;50:608-12.
28. Enciso JM, Hirschi KK. Understanding abnormalities in vascular specification and remodeling. Pediatrics. 2005;116: 228-30.
29. Marler J, Fishman SJ, Kilroy SM, Fang J, Upton J, Mulliken JB, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005;116:38-45.
30. Kapur N, Lambiase P, Rakhit RD, Pearce J, Orchard G, Calonje E, et al. Local and systemic expression of basic fibroblast growth factor in a patient with familial glomangioma. Br J Dermatol. 2002;146:518-22.
31. Hashimoto T, Wu Y, Lawton MT, Yang GY, Barbaro NM, Young WL. Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery. 2005;56:158-65.
32. Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL. Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res. 2001;89:111-3.
33. Redondo P, Martínez-Cuesta A, García-Quetglas E, Idoate A. Active angiogenesis in an extensive arteriovenous vascular malformation: a posible therapeutic target? Arch Dermatol. 2007. En prensa.
34. Soto J. Pathology and pathogenesis of haemangiomas. An Sis Sanit Navar. 2004;27 Suppl 1:27-31.
35. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
36. Oster J, Nielson A. Nucha naevi and interscapular telangiectasis. Acta Paediatr Scand. 1970;59:416.
37. Orten S, Waner M, Flock S, Roberson P, Kincannon J. Port-wine stains: an assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174.
38. Barsky SH, Rosen S, Geer DE, Noe J. The nature and evolution of port wine stains: a computer assisted study. J Invest Dermatol. 1980;74:154.
39. Dahan D, Fenichel GM, El-Said R. Neurocutaneous syndromes. Adolesc Med. 2002;13:495-509.
40. Alonso EM, Sánchez J, Lalanza JJ. Síndrome de Sturge Weber. Med Clin (Barc). 2001;117:320.
41. Comi AM, Hunt P, Vawter MP, Pardo CA, Becker KG, Pevsner J. Increased fibronectin expression in Sturge-Weber syndrome fibroblasts and brain tissue. Pediatr Res. 2003;53: 762-9.
42. Tallman B, Tan OT, Morelli JG, Piepenbrink J, Stafford TJ, Trainor S, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics. 1991;87:323-7.
43. Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol. 1995;10:49-58.
44. Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome secondary to Sturge-Weber syndrome. Jpn J Ophthalmol. 2003;47:233. Author reply 233-4.
45. Kramer U, Kahana E, Shorer Z, Ben-Zeev B. Outcome of infants with unilateral Sturge-Weber syndrome and early onset seizures. Dev Med Child Neurol. 2000;42:756-9.
46. Vilela PF. Sturge-Weber syndrome revisited. Evaluation of encephalic morphological changes with computerized tomography and magnetic resonance. Acta Med Port. 2003; 16:141-8.
47. Pinton F, Chiron C, Enjolras O, Motte J, Syrota A, Dulac O. Early single photon emission computed tomography in Sturge-Weber syndrome. J Neurol Neurosurg Psychiatry. 1997;63:616-21.
48. Pascual-Castroviejo I, Frutos R, Viano J, Pascual-Pascual SI, González P. Cobb syndrome: case report. J Child Neurol. 2002;17:847-9.
49. Danarti R, Happle R, Konig A. Paradominant inheritance may explain familial occurrence of cutis marmorata telangiectatica congenita. Dermatology. 2001;203:208-11.
50. Nagore E, Torrelo A, Zambrano A. Cutis marmorata telangiectática congénita. Revisión de 28 casos. Actas Dermosifiliogr. 1999;90:433-8.
51. Amitai DB, Fichman S, Merlob P, Morad Y, Lapidoth M, Metzker A. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol. 2000;17: 100-4.
52. Shields JA, Shields CL, Koller HP, Federman JL, Koblenzer P, Barbera LS. Cutis marmorata telangiectatica congenita associated with bilateral congenital retinal detachment. Retina. 1990;10:135-9.
53. Torrelo A, Zambrano A, Happle R. Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol. 2003; 148:342-5.
54. Vidaurri-de la Cruz H, Tamayo-Sánchez L, Durán-McKinster C, Orozco-Covarrubias Mde L, Ruiz-Maldonado R. Phakomatosis pigmentovascularis II A and II B: clinical findings in 24 patients. J Dermatol. 2003;30:381-8.
55. Levine C. Primary disorders of the lymphatic vessels. A unified concept. J Pediatr Surg. 1989;24:233.
56. Gross RE. Cystic hygroma. En: The surgery of infancy and childhood. Philadelphia: WB Saunders; 1953. p. 960-70.
57. Ward GE, Hendrick JW, Chambers RG. Cystic hygroma of the head and neck. Surg Obstet Gynecol. 1950;58:41-7.
58. Kennedy TL. Cystic hygroma-lymphoma: a rare, still unclear entity. Laryngoscope. 1989;99:1-10.
59. Broomhead IW. Cystic hygroma of the neck. Br J Plast Surg. 1964;17:225.
60. Nihn TN, Nihn TX. Cystic hygroma in children: report of 126 cases. J Pediatr Surg. 1974;9:191.
61. Boyd JB, Mulliken JB, Kaban LB, Upton J, Murray JE. Skeletal changes associated with vascular malformations. Plast Reconstr Surg. 1984;76:789.
62. Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relations to hemangiomatosis. J Bone Joint Surg. 1955; 37:986-1004.
63. Somoza I, Díaz M, Matínez L, Ros Z, López- Gutiérrez JC. Heterogenicidad del síndrome de Gorham-Stout: asociación a malformaciones linfáticas venosas. An Pediatr (Barc). 2003;58:599-603.
64. Sabin FR. The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat. 1909;9:43.
65. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995;92:3566-70.
66. Schmidt GH. Hemangioma in the zygoma. Ann Plast Surg. 1982;3:330.
67. Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110:1625-35.
68. Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb, a review of 27 cases. J Am Acad Dermatol. 1997;36:219-25.
69. Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, et al. Infants with Kasabach-Merritt syndrome do not have «true» hemangiomas. J Pediatr. 1997;130: 631-40.
70. North PE, Khan T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia. A newly recognized clinicopathological entity. Arch Dermatol. 2004;140:599-606.
71. Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular endothelial growth factor receptor-3 (VEGF-R3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol. 2000;13:180-5.
72. Brindley GV. Glomus tumor of the mediastinum. J Thorac Surg. 1949;18:417-20.
73. Pepper MC, Laubenheiner R, Cripps DJ. Multiple glomus tumors. J Cutan Pathol. 1977;4:244-57.
74. Iqbal A, Cormack GC, Scerri G. Hereditary multiple glomangiomas. Br J Plast Surg. 1998;51:32-7.
75. Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation. Distinct clinicopathologic and genetic entibies. Arch Dermatol. 2004;140:971-6.
76. Oranje AP. Blue rubber bleb nevus syndrome. Pediatr Dermatol. 1986;3:304-10.
77. Tyrell RT, Baumgartner BR, Montemayor KA. Blue rubber bleb nevus syndrome: CT diagnosis of intussusception. Am J Radiol. 1990;154:105-6.
78. Wong CH, Tan YM, Chow WC, Tan PH, Wong WK. Blue rubber bleb nevus syndrome: a clinical spectrum with correlation between cutaneous and gastrointestinal manifestations. J Gastroenterol Hepatol. 2003;18:1000-2.
79. Labauge P, Enjolras O, Bonerandi JJ, Laberge S, Dandyrand, Joujoux JM, et al. An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families. Ann Neurol 1999;45:250-4.
80. Gil-Nagel A, Dubovsky J, Wilcox KJ, Stewart JM, Anderson VE, Leppik IE, et al. Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q. Ann Neurol. 1996;39:311-4.
81. Flye MW, Jordan BP, Schwartz MZ. Management of congenital arteriovenous malformations. Surgery. 1983;94:740.
82. Natali J, Jue-Denis P, Kieffer E, Benhamou M, Tricot JF, Merland JJ, et al. Arteriovenous fistulae of the internal iliac vessels. J Cardiovasc Surg. 1984;25:165-72.
83. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformation of the head and neck natural history and management. Plast Reconstr Surg. 1988;102:643-54.
84. Jacob AG, Driscoll DJ, Shaughnessy WJ, Stanson AW, Clay RP, Gloviczki P, et al. Klippel-Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73: 28-36.
85. Servelle M. Klippel and Trenaunay's syndrome. 768 operated cases. Ann Surg. 1985;201:365-373.
86. Bastida M, Iturbe R. Asimetría de extremidades inferiores con manchas «en vino de Oporto*. An Pediatr (Barc). 2004; 60:589-90.
87. Enrola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet. 2003;73: 1240-9.
88. Timar AA, Sadgephour A, Graf M, Schwartz S, Libby ED, Driscoll DJ, et al. Identification and molecular characteriza-tion of a de novo supernumerary ring chromosome 18 in a patient with Klippel-Trenaunay syndrome. Ann Hum Genet. 2004;68:353-61.
89. Maari C, Frieden IJ. Klippel-Trenaunay syndrome: the importance of «geographic stains» in identifying lymphatic disease and risk of complications. J Am Acad Dermatol. 2004;51:391-8.
90. Bastarrika G, Redondo P, Sierra A, Cano D, Martínez-Cuesta A, López-Gutiérrez JC, et al. New techniques for the evaluation and therapeutic planning of patients with Klippel-Trenaunay syndrome. J Am Acad Dermatol. 2007; 56:242-9.
91. Dogan R, Faruk Dogan O, Oc M, Akata D, Gumus B, Balkanci F. A rare vascular malformation, Klippel-Trenaunay syndrome. Report of a case with deep vein agenesis and review of the literature. J Cardiovasc Surg (Torino). 2003;44:95-100.
92. Berry SA, Peterson C, Mize W, Bloom K, Zachary C, Blasco P, et al. Klippel-Trenaunay syndrome. Am J Med Genet. 1998;79:319-26.
93. Gloviczki P, Stanson AW, Stickler GB, Johnson CM, Toomey BJ, Meland NB, et al. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery 1991;110:469-79.
94. Samuel M, Spitz L. Klippel-Trenaunay syndrome: clinical features, complications and management in children. Br J Surg. 1995;82:757-61.
95. Baskerville PA, Akroyd JS, Thomas ML, Browse NL. The Klippel-Trenaunay syndrome: clinical, radiological, and hemodynamic features and management. Br J Surg. 1985; 72:232-6.
96. Bauza A, Redondo P. Síndrome de Klippel-Trenaunay. Piel. 2005;20:373-82.
97. Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E. The Proteus syndrome. Eur J Pediatr. 1983;140:5-12.
98. Hotamisligil GS. Proteus syndrome and hamartoses with overgrowth. Dysmorphol Clin Genet. 1990;4:87-102.
99. Cohen MM Jr, Neri G, Wesberg R. Overgrowth syndromes. New York: Oxford University Press; 2000.
100. Perkins P, Weiss SW. Spindle cell hemangioendothelioma. An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol. 1996;20: 1196-204.
101. Moreno JC, Valverde F, Medina I, Marchal J. Síndrome de Mafucci. Actas Dermosifiliogr 2002;93:321-4.
102. Kaplan RP, Wang JT, Amron DM, Kaplan L. Maffucci's syndrome: two case reports with a literature review. J Am Acad Dermatol. 1993;29:894-9.
103. Berger TM, Caduff JH. Hemodynamic observations in a newborn with Parkes-Weber syndrome. J Pediatr. 1999; 134:513.
104. Ziyeh S, Spreer J, Rossier J, Strecker R, Hochmuth A, Schumacher M, et al. Parkes Weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography. Eur Radiol. 2004;14:2025-9.
105. Cohen MM Jr. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Gen. 2002; 108:265-74.